MXPA02012944A - Analogos de acido graso para el tratamiento de cancer. - Google Patents
Analogos de acido graso para el tratamiento de cancer.Info
- Publication number
- MXPA02012944A MXPA02012944A MXPA02012944A MXPA02012944A MXPA02012944A MX PA02012944 A MXPA02012944 A MX PA02012944A MX PA02012944 A MXPA02012944 A MX PA02012944A MX PA02012944 A MXPA02012944 A MX PA02012944A MX PA02012944 A MXPA02012944 A MX PA02012944A
- Authority
- MX
- Mexico
- Prior art keywords
- alkyl
- treatment
- fatty acid
- acid analogues
- cancer
- Prior art date
Links
- 235000014113 dietary fatty acids Nutrition 0.000 title abstract 2
- 229930195729 fatty acid Natural products 0.000 title abstract 2
- 239000000194 fatty acid Substances 0.000 title abstract 2
- 150000004665 fatty acids Chemical class 0.000 title abstract 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 125000006686 (C1-C24) alkyl group Chemical group 0.000 abstract 1
- 125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 abstract 1
- 125000004423 acyloxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 206010061289 metastatic neoplasm Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO20003591A NO20003591L (no) | 2000-07-13 | 2000-07-13 | Fettsyreanaloger for behandling av kreft |
| PCT/NO2001/000301 WO2002003983A1 (en) | 2000-07-13 | 2001-07-13 | Fatty acid analogues for the treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA02012944A true MXPA02012944A (es) | 2004-05-17 |
Family
ID=19911376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA02012944A MXPA02012944A (es) | 2000-07-13 | 2001-07-13 | Analogos de acido graso para el tratamiento de cancer. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7378443B2 (enExample) |
| EP (1) | EP1313463B1 (enExample) |
| JP (1) | JP2004502732A (enExample) |
| KR (2) | KR20080071598A (enExample) |
| CN (1) | CN100569228C (enExample) |
| AT (1) | ATE320802T1 (enExample) |
| AU (2) | AU7286001A (enExample) |
| BR (1) | BR0112399A (enExample) |
| CA (1) | CA2414480A1 (enExample) |
| DE (1) | DE60118198T2 (enExample) |
| ES (1) | ES2261441T3 (enExample) |
| MX (1) | MXPA02012944A (enExample) |
| NO (2) | NO20003591L (enExample) |
| NZ (1) | NZ523316A (enExample) |
| RU (1) | RU2283105C2 (enExample) |
| WO (1) | WO2002003983A1 (enExample) |
| ZA (1) | ZA200210028B (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO328803B1 (no) | 2000-03-03 | 2010-05-18 | Thia Medica | Nye fettsyreanaloger |
| CA2490121C (en) | 2002-06-20 | 2013-01-08 | Ic Vec Limited | Modified phospholipids |
| KR20070054637A (ko) | 2004-07-19 | 2007-05-29 | 티아 메디카 에이에스 | 식물유 및/또는 어유 및 비-산화성 지방산 구성요소를포함하는 조성물 |
| NO20053519L (no) * | 2005-07-18 | 2007-01-19 | Thia Medica As | Anvendelse av forbindelser som omfatter fettsyrer |
| US8986253B2 (en) | 2008-01-25 | 2015-03-24 | Tandem Diabetes Care, Inc. | Two chamber pumps and related methods |
| US8408421B2 (en) | 2008-09-16 | 2013-04-02 | Tandem Diabetes Care, Inc. | Flow regulating stopcocks and related methods |
| CA2737461A1 (en) | 2008-09-19 | 2010-03-25 | Tandem Diabetes Care, Inc. | Solute concentration measurement device and related methods |
| CA2921304C (en) | 2009-07-30 | 2018-06-05 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
| US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
| US9555186B2 (en) | 2012-06-05 | 2017-01-31 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
| EP2968568A2 (en) | 2013-03-11 | 2016-01-20 | Life Science Nutrition AS | Natural lipids containing non-oxidizable fatty acids |
| AU2014228387B2 (en) | 2013-03-11 | 2016-09-01 | Sciadonics, Inc. | Lipid compositions containing bioactive fatty acids |
| US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
| DE102014116958B9 (de) * | 2014-11-19 | 2017-10-05 | Trumpf Laser- Und Systemtechnik Gmbh | Optisches System zur Strahlformung eines Laserstrahls, Laserbearbeitungsanlage, Verfahren zur Materialbearbeitung und Verwenden einer gemeinsamen langgezogenen Fokuszone zur Lasermaterialbearbeitung |
| CA2989157A1 (en) * | 2015-06-11 | 2016-12-15 | University Of Miami | Cancer treatment and diagnosis |
| CN105498622B (zh) * | 2015-12-10 | 2017-10-17 | 江南大学 | 一种含硒表面活性剂及其制备方法和应用 |
| CN107235880B (zh) * | 2017-06-30 | 2018-10-30 | 江南大学 | 一种含硒阳离子表面活性剂及其应用 |
| GB201910644D0 (en) * | 2019-07-25 | 2019-09-11 | Coegin Pharma As | Cancer Treatment |
| AU2020405068A1 (en) | 2019-12-18 | 2022-07-07 | Stinginn Llc | Substituted 1,2, 4-triazoles and methods of use |
| US11897888B1 (en) | 2020-04-30 | 2024-02-13 | Stinginn Llc | Small molecular inhibitors of sting signaling compositions and methods of use |
| CN115260964A (zh) * | 2022-08-29 | 2022-11-01 | 烟台市福山义昌精细化工厂 | 一种石油油管丝扣专用密封胶及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0686377B2 (ja) * | 1985-09-30 | 1994-11-02 | 日清製粉株式会社 | がん転移抑制剤 |
| SE9103572D0 (sv) * | 1991-11-29 | 1991-11-29 | Astra Ab | Organic salts of n,n'-diacetyl cystine |
| JPH0797320A (ja) * | 1993-08-04 | 1995-04-11 | Takuma Sasaki | 制癌剤 |
| US6358915B1 (en) * | 1995-03-07 | 2002-03-19 | George Washington University | Methods for inhibiting metastasis |
| WO1996032101A1 (en) * | 1995-04-10 | 1996-10-17 | Taiho Pharmaceutical Co., Ltd. | Cancerous metastasis inhibitor |
| NO952796D0 (no) * | 1995-07-14 | 1995-07-14 | Rolf Berge | Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater |
| JP4549443B2 (ja) * | 1996-12-11 | 2010-09-22 | ダナ−ファーバー キャンサー インスティテュート インク． | 腫瘍細胞の成長を阻害するための方法および製薬学的組成物 |
| DE19700774A1 (de) * | 1997-01-13 | 1998-07-16 | Hoechst Ag | Antiadhäsive Sulfatid-Mimetika |
| AU7240398A (en) * | 1998-05-08 | 1999-11-29 | Rolf Berge | Use of non-beta-oxidizable fatty acid analogues for treatment of syndrome-x conditions |
| JP4993878B2 (ja) * | 2005-06-28 | 2012-08-08 | ダイキョーニシカワ株式会社 | 多気筒エンジンの吸気装置 |
-
2000
- 2000-07-13 NO NO20003591A patent/NO20003591L/no not_active Application Discontinuation
-
2001
- 2001-07-13 DE DE60118198T patent/DE60118198T2/de not_active Expired - Fee Related
- 2001-07-13 AT AT01952065T patent/ATE320802T1/de not_active IP Right Cessation
- 2001-07-13 WO PCT/NO2001/000301 patent/WO2002003983A1/en not_active Ceased
- 2001-07-13 BR BR0112399-8A patent/BR0112399A/pt not_active Application Discontinuation
- 2001-07-13 CA CA002414480A patent/CA2414480A1/en not_active Abandoned
- 2001-07-13 AU AU7286001A patent/AU7286001A/xx active Pending
- 2001-07-13 AU AU2001272860A patent/AU2001272860B2/en not_active Ceased
- 2001-07-13 ES ES01952065T patent/ES2261441T3/es not_active Expired - Lifetime
- 2001-07-13 KR KR1020087014318A patent/KR20080071598A/ko not_active Withdrawn
- 2001-07-13 CN CNB018127177A patent/CN100569228C/zh not_active Expired - Fee Related
- 2001-07-13 US US10/312,901 patent/US7378443B2/en not_active Expired - Fee Related
- 2001-07-13 NZ NZ523316A patent/NZ523316A/en not_active IP Right Cessation
- 2001-07-13 MX MXPA02012944A patent/MXPA02012944A/es active IP Right Grant
- 2001-07-13 RU RU2002134754/15A patent/RU2283105C2/ru not_active IP Right Cessation
- 2001-07-13 JP JP2002508437A patent/JP2004502732A/ja active Pending
- 2001-07-13 EP EP01952065A patent/EP1313463B1/en not_active Expired - Lifetime
- 2001-07-13 KR KR1020037000477A patent/KR100861428B1/ko not_active Expired - Fee Related
-
2002
- 2002-12-11 NO NO20025930A patent/NO324634B1/no not_active IP Right Cessation
- 2002-12-11 ZA ZA200210028A patent/ZA200210028B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR100861428B1 (ko) | 2008-10-02 |
| DE60118198T2 (de) | 2007-01-25 |
| AU2001272860B2 (en) | 2005-11-24 |
| AU7286001A (en) | 2002-01-21 |
| EP1313463B1 (en) | 2006-03-22 |
| KR20030016399A (ko) | 2003-02-26 |
| US7378443B2 (en) | 2008-05-27 |
| ZA200210028B (en) | 2004-01-26 |
| CA2414480A1 (en) | 2002-01-17 |
| ES2261441T3 (es) | 2006-11-16 |
| CN1441671A (zh) | 2003-09-10 |
| NO20003591D0 (no) | 2000-07-13 |
| NO20025930D0 (no) | 2002-12-11 |
| CN100569228C (zh) | 2009-12-16 |
| NO20003591L (no) | 2002-01-14 |
| BR0112399A (pt) | 2003-05-27 |
| EP1313463A1 (en) | 2003-05-28 |
| HK1057473A1 (zh) | 2004-04-08 |
| JP2004502732A (ja) | 2004-01-29 |
| NO324634B1 (no) | 2007-11-26 |
| ATE320802T1 (de) | 2006-04-15 |
| WO2002003983A1 (en) | 2002-01-17 |
| RU2283105C2 (ru) | 2006-09-10 |
| KR20080071598A (ko) | 2008-08-04 |
| DE60118198D1 (de) | 2006-05-11 |
| US20040024063A1 (en) | 2004-02-05 |
| NZ523316A (en) | 2004-09-24 |
| NO20025930L (no) | 2003-01-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA02012944A (es) | Analogos de acido graso para el tratamiento de cancer. | |
| MXPA05014198A (es) | Activos antitranspirantes de aluminio/zirconio/glicina estabilizados con betaina. | |
| PT1075259E (pt) | Novos analogos gordos para o tratamento de diabetes | |
| AU2003248533A1 (en) | Fluorinated phosphonic acids | |
| CA2407100A1 (en) | 1-aroyl-piperidinyl benzamidines | |
| ES2193874A1 (es) | Compuestos naturales y derivados de estos para la prevencion y el tratamiento de enfermedades cardiovasculares, hepaticas, renales y cosmeticas. | |
| MXPA04006542A (es) | Composiciones bucales estables que contienen complejos de fosfopeptido de caseina y fluooruro. | |
| KR970074765A (ko) | 비타민 d₃ 동족체 | |
| MXPA03002629A (es) | Analogos de acido graso para el tratamiento de enfermedades proliferativas de la piel. | |
| MXPA04006541A (es) | Composiciones bucales estables que contienen complejos de fosfopeptido de caseina y fluoruro. | |
| MX236472B (es) | Nuevos analogos de acidos grasos. | |
| TR199901089T2 (xx) | Aminhidrofl�oridler ve bunlar�n oral hijyen preparasyonlar� olarak kullan�mlar�. | |
| KR970074763A (ko) | 불소화된 비타민 d₃ 유사체 | |
| MXPA03004427A (es) | Analogos de acido graso para el tratamiento de desordenes inflamatorios y autoinmunes. | |
| AU1022999A (en) | 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs | |
| IL146190A0 (en) | Dermal anesthetic agents | |
| EA200100297A1 (ru) | Моногидрат гидробромида элетриптана | |
| DK1250337T3 (da) | Substituerede homopiperidinylbenzimidazol-analoger som fundus-relaksanter | |
| GB0105837D0 (en) | Pharmaceutical compositions including alginates | |
| IL157241A0 (en) | Malic acid addition salts of terbinafine | |
| PT1651596E (pt) | Novos derivados de 4,4?-ditiobis-(3-aminobutano-1-sulfonatos) e composições que os contêm | |
| UA81664C2 (ru) | Производные дифенилмочевины и их применение, как блокаторов хлоридных каналов | |
| BR9809661A (pt) | Redução de halogenetos aromáticos | |
| MY130184A (en) | Dermal anesthetic agents | |
| AR104392A2 (es) | Un compuesto de prostaglandina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |